BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates

  Cash, cash equivalents and marketable securities as of September 30, 2017 were $133.4 million, compared with $100.3 million as of December 31, 2016.

  November 10, 2017

   · 

  9 min read
• Business

  Braskem Signs Partnership With Haldor Topsoe to Develop Biobased MEG

  The agreement calls for the construction of a demonstration plant in Denmark, with operation slated to begin in 2019.

  November 10, 2017

   · 

  3 min read
• CPhI Global Pharma Index: India’s Reputation Improving and Ranks Third Most Competitive Nation

  CPhI & P-MEC India - organised by UBM – is set to welcome more than 50,000 attendees as the CPhI Global Pharma Index shows the country’s efforts to improve its reputation are paying dividends.

  November 10, 2017

   · 

  3 min read
• Business

  Stemline Therapeutics Reports Third Quarter 2017 Financial Results

  Stemline ended the third quarter of 2017 with $79.9 million in cash, cash equivalents and investments, as compared to $93.2 million as of June 30, 2017, which reflects cash expenditures of $13.3 million for the quarter.

  November 10, 2017

   · 

  7 min read
• Drug Development

  NANOBIOTIX Provides Update on the Global Development of Its Lead Product NBTXR3

  Nanobiotix’s lead product, NBTXR3, has a universal physical mode of action which is designed for the local destruction of tumors

  November 10, 2017

   · 

  6 min read
• CMS Issues New Reimbursement Codes For Ameluz and for Photodynamic Therapy

  The J-code, which will become effective on January 2, 2018, provides reimbursement coding clarity for physicians prescribing Ameluz in the U.S.

  November 10, 2017

   · 

  2 min read
• CorWave Receives 2017 Deloitte ‘Technology Fast 50 Biotech of the Future’ Award of the Parisian Region

  CorWave announced today that it received the ‘Deloitte In Extenso Technology Fast 50 Biotech of the Future’ award for the Parisian Region which rewards the outstanding contribution of technology companies to economic growth.

  November 10, 2017

   · 

  4 min read
• Business

  Zosano Pharma Reports Third Quarter 2017 Financial Results and Operational Update

  Zosano reported a net loss for the third quarter of 2017 of $7.9 million.

  November 10, 2017

   · 

  7 min read
• Genetown

  Takeda Supports Launch of Five-Year, $1M Initiative Spearheaded by the Massachusetts Life Sciences Center to Back Women-Driven Early Stage Companies

  Takeda announced its support of the launch of the MassNextGen initiative, a five-year, $1M program anchored by Takeda and matched by the Massachusetts Life Sciences Center (MLSC), to support women-led or controlled early-stage biotech companies.

  November 10, 2017

   · 

  3 min read
• Biotech Beach

  BioDiscovery Launches Nxclinical 4.0, a Unique System Allowing Analysis and Interpretation of CNV, SNV, and AOH From A Single NGS Assay

  BioDiscovery launched, at the 2017 American Society of Human Genetics Meeting, a unique software solution for interrogation of copy number, sequence variants, and allelic changes obtained from a single NGS assay.

  November 10, 2017

   · 

  5 min read